¼¼°èÀÇ ¹ÙÀÌ¿À ÇÁ·Î¼¼½º ÀÚµ¿È­ ½ÃÀå º¸°í¼­(2025³â)
Bioprocess Automation Global Market Report 2025
»óǰÄÚµå : 1681962
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,426,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,288,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,150,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹ÙÀÌ¿À ÇÁ·Î¼¼½º ÀÚµ¿È­ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ±Þ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ ¼ºÀåÀº »ý»ê¼º Çâ»ó, ±ÔÁ¤ Áؼö, ÇÁ·Î¼¼½º ÃÖÀûÈ­, ¿¹Ãø À¯Áöº¸¼ö ¿¹Ãø À¯Áöº¸¼ö ¹× ½Ç½Ã°£ ºÐ¼®¿¡ ±âÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕ, ¸ðµâ½Ä ¹ÙÀÌ¿À ÇÁ·Î¼¼½Ì, À¯ÀüÀÚ Ä¡·á¸¦ À§ÇÑ °øÁ¤ Á¦¾î Àü·«, À¯ÀüÀÚ Ä¡·á¸¦ À§ÇÑ °øÁ¤ Á¦¾î Àü·«, µ¥ÀÌÅÍ ºÐ¼® ¹× ½Ã°¢È­ µîÀÌ ÀÖ½À´Ï´Ù.

°³ÀÎ ¸ÂÃãÇü ÀǾàǰÀÇ Áõ°¡´Â ÇâÈÄ ¹ÙÀÌ¿À ÇÁ·Î¼¼½º ÀÚµ¿È­ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.°³ÀÎ ¸ÂÃãÇü ÀÇÇÐÀº ÀÇ·á °áÁ¤, Áø·á, ÁßÀç ¹× Ä¡·á¸¦ °¢ ȯÀÚÀÇ °³º° Ư¼º¿¡ ¸Â°Ô Á¶Á¤ÇÏ´Â ÀÇ·á Á¢±Ù ¹æ½ÄÀ» ¸»ÇÕ´Ï´Ù. ¹ÙÀÌ¿À ÇÁ·Î¼¼½º ÀÚµ¿È­´Â ȯÀÚ ¸ÂÃãÇü ÀǾàǰ »ý»êÀÇ Á¤¹Ð¼º°ú È®À强À» Áö¿øÇÔÀ¸·Î½á °³ÀÎ ¸ÂÃãÇü ÀÇÇÐÀ» ½ÇÇöÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù.¹Ì±¹ÀÇ Àü¹® ȸ¿ø ´ÜüÀÎ Personalized Medicine Coalition¿¡ µû¸£¸é 2022³â¿¡ »õ·Î ½ÂÀÎµÈ °³ÀÎ ¸ÂÃãÇü ÀǾàǰÀº 12°³·Î Àüü ½Å±Ô ½ÂÀÎ Ä¡·á¹ýÀÇ ¾à 34%¸¦ Â÷ÁöÇÏ¿© Àü³â ´ëºñ Å©°Ô Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÀÌó·³ °³ÀÎ ¸ÂÃãÇü ÀǾàǰÀÇ Áõ°¡´Â ¹ÙÀÌ¿À ÇÁ·Î¼¼½º ÀÚµ¿È­ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿À ÇÁ·Î¼¼½º ÀÚµ¿È­ ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷µéÀº ¹ÙÀÌ¿À¸®¾×ÅÍ¿Í °°Àº Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» °³¹ßÇÏ¿© ¹ÙÀÌ¿À ÇÁ·Î¼¼½º ¿î¿µÀ» °£¼ÒÈ­Çϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À¸®¾×ÅÍ´Â »ý¹°ÇÐÀû ¹× È­ÇÐÀû ¹ÝÀÀÀ» À§ÇÑ ÃÖÀûÀÇ Á¦¾î ȯ°æÀ» Á¦°øÇÏ´Â ¿£Áö´Ï¾î¸µ ½Ã½ºÅÛ ¶Ç´Â ÀåÄ¡ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 4¿ù, Ä¡·áÁ¦ÀÇ °³¹ß°ú Á¦Á¶¸¦ ¹ßÀü½ÃŰ°í °¡¼ÓÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ±â¼ú°ú ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ¹Ì±¹ ±â¹Ý ±â¼ú ȸ»çÀÎ Cytiva´Â ÀÏȸ¿ë ¾÷½ºÆ®¸² ¹ÙÀÌ¿À ÇÁ·Î¼¼½Ì ÀÛ¾÷À» °£¼ÒÈ­ÇÏ´Â X-Ç÷§Æû ¹ÙÀÌ¿À¸®¾×Å͸¦ Ãâ½ÃÇß½À´Ï´Ù. X-Ç÷§Æû ¹ÙÀÌ¿À¸®¾×ÅÍ´Â ÀÛµ¿ÀÌ °£ÆíÇϰí À¯¿¬ÇÏ¸ç °øÁ¤ È¿À²¼ºÀÌ ³ô½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº° ¹× ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Bioprocess automation is using automated systems to monitor and control the bioprocessing workflow, which involves living cells, organisms, or components to produce biological products such as biopharmaceuticals. Biopharmaceutical businesses use bioprocess automation for better process control and optimization, higher product quality, decreased variability, increased throughput and efficiency, cost savings, and scalability.

The main components of bioprocess automation are sensors, actuators, and controllers. Sensors are devices that detect and respond to inputs from the physical environment, converting them into electronic signals, which are used to monitor various parameters such as temperature, pH, dissolved oxygen, and pressure. The scale of operation includes preclinical operations, clinical operations, and commercial operations with batch, fed-batch, and perfusion modes of compatibility with bioprocessing systems include single-use systems, stainless steel, and others.

The main components of bioprocess automation are sensors, actuators, and controllers. Sensors are devices that detect and respond to inputs from the physical environment, converting them into electronic signals, which are used to monitor various parameters such as temperature, pH, dissolved oxygen, and pressure. The scale of operation includes preclinical operations, clinical operations, and commercial operations with batch, fed-batch, and perfusion modes of compatibility with bioprocessing systems include single-use systems, stainless steel, and others.

The bioprocess automation market size has grown rapidly in recent years. It will grow from $5.67 billion in 2024 to $6.37 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increased efficiency, cost reduction, risk mitigation, rising demand for remote monitoring and control, and reduced labor dependency.

The bioprocess automation market size is expected to see rapid growth in the next few years. It will grow to $10.27 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to enhanced productivity, regulatory compliance, process optimization, predictive maintenance predictive maintenance, and real-time analytics. Major trends in the forecast period include integration of ai and machine learning, modular bioprocessing, process control strategies for gene therapy, process control strategies for gene therapy, and data analytics and visualization.

The increasing number of personalized medicines is expected to fuel the growth of the bioprocess automation market going forward. Personalized medicine refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to the individual characteristics of each patient. Bioprocess automation helps personalized medicine by enabling precision and scalability in producing patient-specific drugs. For instance, according to Personalized Medicine Coalition, a US-based professional membership organization, in 2022, approving 12 new personalized medicines represented approximately 34% of all newly approved therapies, indicating a substantial increase from previous years. Therefore, the increasing number of personalized medicines is driving the growth of the bioprocess automation market.

Major companies operating in the bioprocess automation market are developing innovative solutions, such as bioreactors to simplify bioprocessing operations. A bioreactor is an engineered system or device that provides an optimal and controlled environment for biological and chemical reactions. For instance, in April 2023, Cytiva, a US-based technology company that provides technologies and services that help advance and accelerate the development and manufacture of therapeutics, launched X-platform bioreactors to simplify single-use upstream bioprocessing operations. It is easy to operate, flexible, and more efficient in the process. It was first offered in 50 and 200 L capacities. They can increase process efficiency through ergonomic improvements, production capability, and simplified supply chain operations. The X-platform bioreactors can be used to manufacture cell and gene therapies as well as viral vectors, in addition to monoclonal antibodies (mAbs).

In April 2022, MilliporeSigma, a US-based life science division of Merck KGaA, acquired Lonza's Modular Automated Sampling Technology (MAST) platform for an undisclosed amount. This acquisition is designed to enhance MilliporeSigma's position in the bioprocessing market by expanding its portfolio of tools for biopharmaceutical manufacturing. By integrating the MAST platform, MilliporeSigma aims to offer more advanced and automated solutions for the pharmaceutical, biotechnology, and nutrition sectors. Lonza, a Switzerland-based company, is a key player in the manufacturing industry serving these sectors. This move strengthens MilliporeSigma's capabilities in the rapidly growing bioprocessing industry.

Major companies operating in the bioprocess automation market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Corporation, Danaher Corporation, Amgen Inc., Merck KGaA, Parker-Hannifin Corporation, CSL Behring LLC, Rockwell Automation Inc., Agilent Technologies Inc., Lonza Group AG, Waters Corporation, Getinge AB, Eppendorf AG, Repligen Corporation, BIONET Research S.A., Flotek Industries Inc., Pierre Guerin SAS, Bioengineering AG, Genedata AG, ILS Automation, INFORS AG, Synthace Limited, Automated Control Concepts Inc., BlueSens gas sensor GmbH, DISTek Integration Inc., Securecell AG, Flownamics Analytical Instruments Inc., Inscripta Inc., PendoTECH Inc., Sartorius Stedim Biotech S.A.

North America was the largest region in the bioprocess automation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess automation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioprocess automation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioprocess automation market includes revenues earned by entities by providing services such as process automation, instrumentation and control systems, training and support services, and maintenance and upgrades. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioprocess automation market also includes sales of bioreactors, fermenters, laboratory information management systems (LIMS), and integrated bioprocess platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioprocess Automation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioprocess automation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bioprocess automation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioprocess automation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Bioprocess Automation Market Characteristics

3. Bioprocess Automation Market Trends And Strategies

4. Bioprocess Automation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Bioprocess Automation Growth Analysis And Strategic Analysis Framework

6. Bioprocess Automation Market Segmentation

7. Bioprocess Automation Market Regional And Country Analysis

8. Asia-Pacific Bioprocess Automation Market

9. China Bioprocess Automation Market

10. India Bioprocess Automation Market

11. Japan Bioprocess Automation Market

12. Australia Bioprocess Automation Market

13. Indonesia Bioprocess Automation Market

14. South Korea Bioprocess Automation Market

15. Western Europe Bioprocess Automation Market

16. UK Bioprocess Automation Market

17. Germany Bioprocess Automation Market

18. France Bioprocess Automation Market

19. Italy Bioprocess Automation Market

20. Spain Bioprocess Automation Market

21. Eastern Europe Bioprocess Automation Market

22. Russia Bioprocess Automation Market

23. North America Bioprocess Automation Market

24. USA Bioprocess Automation Market

25. Canada Bioprocess Automation Market

26. South America Bioprocess Automation Market

27. Brazil Bioprocess Automation Market

28. Middle East Bioprocess Automation Market

29. Africa Bioprocess Automation Market

30. Bioprocess Automation Market Competitive Landscape And Company Profiles

31. Bioprocess Automation Market Other Major And Innovative Companies

32. Global Bioprocess Automation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioprocess Automation Market

34. Recent Developments In The Bioprocess Automation Market

35. Bioprocess Automation Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â